LWM
LKFT

Lenox Wealth Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Lenox Wealth Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$852K Buy
4,321
+424
+11% +$87.8K 0.26% 74
2020
Q1 		$763K Buy
+3,897
New +$838K 0.26% 60

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lenox Wealth Management's LKFT Position: Q2 2020 in Review

Lenox Wealth Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 11% in Q2 2020, buying an estimated $87.8K and bringing the position to 4,321 shares worth $852K. The position accounts for 0.26% of the portfolio, ranked #74.

Lenox Wealth Management first reported a position in LKFT in Q1 2020 and has held it in 2 quarters since. 142 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

  • Lenox Wealth Management held 4,321 shares of Lakefront Biotherapeutics American Depositary Shares worth $852K as of Q2 2020.
  • Lenox Wealth Management bought 424 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $87.8K.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.26% of Lenox Wealth Management's portfolio in Q2 2020, its #74 holding.
  • Lenox Wealth Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 2 quarters since.
  • 142 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.